Jubilant Pharmova
JUBLPHARMA.NS
#4188
Rank
S$2.88 B
Marketcap
$18.20
Share price
1.06%
Change (1 day)
164.11%
Change (1 year)

Earnings for Jubilant Pharmova (JUBLPHARMA.NS)

Earnings in 2024 (TTM): S$0.11 Billion

According to Jubilant Pharmova's latest financial reports the company's current earnings are S$0.82 Billion. In 2023 the company made an earning of S$22.14 Million a decrease over its 2022 earnings that were of S$37.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jubilant Pharmova from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.11 B400%
2023 S$22.14 M-41.66%
2022 S$37.95 M-73.24%
2021 S$0.14 B-19.4%
2020 S$0.17 B19.42%
2019 S$0.14 B-35.23%
2018 S$0.22 B37.8%
2017 S$0.16 B27.68%
2016 S$0.12 B15.18%
2015 S$0.11 B330.67%
2014 S$26.07 M41.6%
2013 S$18.41 M-111.81%
2012 -S$0.16 Billion